Legend Biotech Corporation announced that its Board of Directors has appointed Dr. Frank Zhang to serve as Chief Executive Officer, effective immediately. Dr. Zhang will succeed Dr. Yuan Xu, who has resigned from her position as Chief Executive Officer for personal reasons. Dr. Zhang has concurrently stepped down as Chief Executive Officer of GenScript, Legend Biotech's majority shareholder, in order to focus his attention on Legend Biotech. Dr. Zhang has served as the Chairman of Board of Directors of Legend Biotech since May 2015. Dr. Zhang has been the chairman, an executive director and chief executive officer of GenScript since 2015. He co-founded the GenScript group in 2002 and has been the director of various group companies prior to GenScript becoming the holding company of the group companies pursuant to the corporate reorganization for GenScript's initial public offering in 2015.